Harbin Pharmaceutical Group Co

Harbin Pharmaceutical Group Co Dividend Coverage

The Dividend Coverage Ratio of Harbin Pharmaceutical Group Co (600664.SS) as of Oct 17, 2026 is 0.27. In the previous year, Dividend Coverage Ratio was 0.33 — a change of -16.46% (lower).

Dividend Coverage

0.27

YoY

-16.46%

Last updated:

Dividend Coverage Ratio of Harbin Pharmaceutical Group Co is 2018 0.27 . Dividend Coverage Ratio of Harbin Pharmaceutical Group Co was 2017 0.33 . It decreases by -16.46% lower compared to the previous year.

The Harbin Pharmaceutical Group Co Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2014
1.93 CNY
Jan 1, 2015
0.30 CNY
Jan 1, 2017
0.33 CNY
Jan 1, 2018
0.27 CNY
The Harbin Pharmaceutical Group Co Dividend Coverage history
YEARDividend CoverageYoY
0.27-16.46%
0.33+8.19%
0.30-84.34%
1.93—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Harbin Pharmaceutical Group Co Stock analysis

What does Harbin Pharmaceutical Group Co do? Harbin Pharmaceutical Group Co Ltd is a pharmaceutical company based in Harbin, China, operating within the Health Care sector. The company engages in the research, development, manufacture, wholesale, and retail of pharmaceutical products. It has 10,064 employees, with its headquarters located in Harbin, Heilongjiang Province. Founded through an IPO on June 29, 1993, the company is listed on the Shanghai Stock Exchange under the ticker 600664.SS. Harbin Pharmaceutical Group's primary business activities include innovative research and development in high-tech fields such as antibiotics, modern Chinese medicine, and biopharmaceuticals. The company operates across multiple sectors including antibiotics, over-the-counter drugs, health products, traditional and modern Chinese medicine, biomedicine, and pharmaceutical commerce. Its product portfolio features calcium gluconate oral solution, zinc gluconate oral solution, amoxicillin capsules, Shuanghuanglian oral solution, alprostadil injection, pediatric paracetamol Huangnamin granules, lacidipine tablets, hydrochloric acid for injection Cefotiam, ibuprofen granules, and Xingaizhonggai high calcium tablets. The company's website is https://www.hayao.com/, though the source description provided is untrusted and should not be relied upon for factual accuracy. Harbin Pharmaceutical Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harbin Pharmaceutical Group Co stock

Dividend Coverage Ratio of Harbin Pharmaceutical Group Co is 0.27 in 2018.

Dividend Coverage Ratio of Harbin Pharmaceutical Group Co changed from 0.33 to 0.27, representing a -16.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Harbin Pharmaceutical Group Co since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Harbin Pharmaceutical Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — Harbin Pharmaceutical Group Co

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — Harbin Pharmaceutical Group Co